Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 60 | 0 | 12 | 0 | €829.40 | €824.11 | -0.638% |
| Biogen Inc. | 50 | 1 | 2 | 0 | €211.00 | €293.22 | 38.969% |
| Vertex Pharmaceuticals Inc. | 50 | 2 | 5 | 0 | €442.50 | €429.29 | -2.985% |
| Regeneron Pharmaceuticals Inc. | 41 | 1 | 5 | 0 | €990.80 | €1,025.4 | 3.487% |
| Alnylam Pharmace. | 39 | 1 | 3 | 1 | €207.50 | €244.57 | 17.863% |
| Johnson & Johnson | 38 | 1 | 6 | 0 | €138.90 | €187.15 | 34.739% |
| Cytokinetics Inc. | 34 | 1 | 4 | 0 | €48.40 | €83.21 | 71.911% |
| Insmed Inc. | 33 | 0 | 15 | 0 | €62.50 | €65.83 | 5.327% |
| Neurocrine Bioscience | 33 | 0 | 4 | 0 | €124.45 | €140.87 | 13.192% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €124.00 | €125.34 | 1.079% |
| Intra-Cellular Therapies Inc. | 30 | 0 | 5 | 0 | €70.50 | €83.49 | 18.430% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.41 | €40.66 | 53.955% |
| AbbVie Inc. | 30 | 0 | 9 | 0 | €160.90 | €175.39 | 9.008% |
| Acadia Pharmaceuticals | 28 | 1 | 0 | 0 | €14.79 | €31.78 | 114.903% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €296.30 | €300.48 | 1.411% |